Pediatr. praxi. 2011;12(4):273-275

Retrobulbar optic neuritis and development of multiple sclerosis in adolescent

prof.MUDr.Vladimír Mihál, CSc.1, MUDr.Kamila Michálková2, MUDr.David Horák2, MUDr.Marta Neklanová1, MUDr.Barbora Babáková3
1 Dětská klinika LF UP a FN v Olomouci
2 Radiologická klinika LF UP a FN v Olomouci
3 Oční klinika LF UP a FN v Olomouci

Association of recurrent optic neuritis and subsequent development of multiple sclerosis in children are common and well known, close

collaboration among ophtalmologists and neurologists is needful. We report on recurrent retrobulbar optic neuritis and subsequent

multiple sclerosis in a 14-years old girl.

Keywords: multiple sclerosis, children and adolescents, retrobulbar optic neuritis

Published: September 2, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mihál V, Michálková K, Horák D, Neklanová M, Babáková B. Retrobulbar optic neuritis and development of multiple sclerosis in adolescent. Pediatr. praxi. 2011;12(4):273-275.
Download citation

References

  1. Diblík P, Kuthan P, Sklenka P. Neuritida zrakového nervu u roztroušené sklerózy mozkomíšní, typické obrazy a úskalí diferenciální diagnostiky. Neurol praxi 2011; 12(3): 156-159.
  2. Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6: 887-902. Go to original source... Go to PubMed...
  3. Visudhiphan P, Chiemchanya S, Santadusit S. Optic neuritis in children: recurrence and subsequent development of multiple sclerosis. Pediatr Neurol 1995; 13: 293-295. Go to original source... Go to PubMed...
  4. Havrdová E. Roztroušená skleróza. Cesk Slov Neurol N 2008; 104(2): 121-132.
  5. Tanembaum SN. Therapy of multiple sclerosis in children and adolescents. Clin Neurol Neurosurg 2010; 112: 633-640. Go to original source... Go to PubMed...
  6. Krupp L, Banwell B, Tanembaum S, et al. For the International Pediatric MS Group. Consensus definitions proposed for pediatric multiple sclerosis. Neurology 2007; 68: S7-S12. Go to original source... Go to PubMed...
  7. Sindern E, Hass J, Stark E, Wurster U. Early onset MS under the age 16: clinical and paraclinical features. Acta Neurol Scand 1992; 86: 280-284. Go to original source... Go to PubMed...
  8. Havrdová E. Vývoj nových léků v oblasti RS - změnila se prognóza pacienta? Neurol praxi 2011; 12(3): 170-174.
  9. Hahn CD, Shroff MM, Blaser S, Banwell BL. MRI criteria for multiple sclerosis: evaluation ina pediatric cohort. Neurology 2004; 62: 806-808. Go to original source... Go to PubMed...
  10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the, ,McDonald Criteria." Annals of Neurology 2005; 58: 840-846. Go to original source... Go to PubMed...
  11. Bednářová E, Štourač P. Intratekální syntéza specifických antivirových protilátek u atakovitého a primárně chronickoprogresivního průběhu roztroušené sklerózy. Neurol praxi 2009; 10(5): 297-299.
  12. Zeman AZJ, Kidd J, McLean BN. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatr 1996; 60: 27-30. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.